VIP (10mg) protocols focus on Vasoactive Intestinal Peptide, a naturally occurring neuropeptide involved in regulating immune response, inflammation, vascular tone, and smooth muscle activity. It is being studied for its potential role in supporting respiratory function, neurological balance, gut health, and inflammatory regulation. This guide outlines a subcutaneous administration approach optimized for the 10 mg vial format.
Concise summary of the subcutaneous regimen.
Suggested approach for the 10 mg vial format.
Vasoactive Intestinal Peptide (VIP) is an endogenous neuropeptide that functions as both a neurotransmitter and immunomodulator. It binds to VPAC receptors (VPAC1 and VPAC2), which are widely expressed in immune cells, the central nervous system, and smooth muscle tissues.
Through these receptors, VIP may help regulate inflammatory cytokine production, support vasodilation, and influence autonomic nervous system balance. It also plays a role in mucosal barrier integrity in the gut and respiratory tract. Research suggests VIP may help shift immune activity toward a more regulated, anti-inflammatory profile while supporting tissue protection mechanisms.
Observations based on preclinical and early clinical research.
Potential Benefits:
Possible Side Effects: